https://www.tctmd.com/news/enoxaparin-tops-aspirin-preventing-vte-after-hip-or-knee-arthroplasty
0
0
32 words
0
Comments
The benefit in CRISTAL was driven by a lower rate of below-knee DVT, however, raising questions about clinical importance.
You are the first to view
Create an account or login to join the discussion